Rapid Micro Biosystems, Inc. (RPID)Healthcare | Medical Devices | Lexington, United States | NasdaqCM
2.28 USD
+0.02
(0.885%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.29 +0.01 (0.443%) ⇧ (April 17, 2026, 6:20 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 1:09 a.m. EDT
RPID faces short-term volatility from high beta and extreme price noise, compounded by deteriorating fundamentals with negative cash flow, negative margins, and a risky earnings trajectory leading into the 2025/2026 reporting periods; long-term outlook is weak due to lack of profitability despite growth in revenue, and no dividend yield is available. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.253495 |
| AutoARIMA | 0.254070 |
| AutoETS | 0.262443 |
| AutoTheta | 0.332724 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 51.17 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.046 |
| Excess Kurtosis | -1.34 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 71.897 |
| Revenue per Share | 0.752 |
| Market Cap | 104,348,848 |
| Forward P/E | -2.77 |
| Beta | 1.60 |
| Profit Margins | -140.30% |
| Website | https://www.rapidmicrobio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.00440526 |
| Address1 | 25 Hartwell Avenue |
| All Time High | 27.04 |
| All Time Low | 0.58 |
| Ask | 2.36 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 195,080 |
| Average Daily Volume3 Month | 230,259 |
| Average Volume | 230,259 |
| Average Volume10Days | 195,080 |
| Beta | 1.602 |
| Bid | 2.21 |
| Bid Size | 2 |
| Book Value | 0.747 |
| City | Lexington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.28 |
| Current Ratio | 3.309 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.355 |
| Day Low | 2.24 |
| Debt To Equity | 71.897 |
| Display Name | Rapid Micro Biosystems |
| Earnings Call Timestamp End | 1,773,318,600 |
| Earnings Call Timestamp Start | 1,773,318,600 |
| Earnings Timestamp | 1,773,318,600 |
| Earnings Timestamp End | 1,778,243,400 |
| Earnings Timestamp Start | 1,778,243,400 |
| Ebitda | -44,640,000 |
| Ebitda Margins | -1.32909 |
| Enterprise To Ebitda | -1.989 |
| Enterprise To Revenue | 2.644 |
| Enterprise Value | 88,800,624 |
| Eps Current Year | -0.92333 |
| Eps Forward | -0.82333 |
| Eps Trailing Twelve Months | -1.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.218 |
| Fifty Day Average Change | -0.93799996 |
| Fifty Day Average Change Percent | -0.2914854 |
| Fifty Two Week Change Percent | 0.440526 |
| Fifty Two Week High | 4.94 |
| Fifty Two Week High Change | -2.66 |
| Fifty Two Week High Change Percent | -0.53846157 |
| Fifty Two Week Low | 2.01 |
| Fifty Two Week Low Change | 0.26999998 |
| Fifty Two Week Low Change Percent | 0.13432835 |
| Fifty Two Week Range | 2.01 - 4.94 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,626,355,800,000 |
| Float Shares | 22,375,521 |
| Forward Eps | -0.82333 |
| Forward P E | -2.769242 |
| Free Cashflow | -15,771,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 171 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.031170001 |
| Gross Profits | 1,047,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09937 |
| Held Percent Institutions | 0.57278 |
| Implied Shares Outstanding | 45,767,040 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-07-15 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. |
| Long Name | Rapid Micro Biosystems, Inc. |
| Market | us_market |
| Market Cap | 104,348,848 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_7984788 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -47,123,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 104,348,851 |
| Number Of Analyst Opinions | 3 |
| Open | 2.26 |
| Operating Cashflow | -31,062,000 |
| Operating Margins | -1.08234 |
| Payout Ratio | 0.0 |
| Phone | 978 349 3200 |
| Post Market Change | 0.010100126 |
| Post Market Change Percent | 0.442988 |
| Post Market Price | 2.2901 |
| Post Market Time | 1,776,464,425 |
| Previous Close | 2.26 |
| Price Eps Current Year | -2.469323 |
| Price Hint | 4 |
| Price To Book | 3.052209 |
| Price To Sales Trailing12 Months | 3.1068225 |
| Profit Margins | -1.4030099 |
| Quick Ratio | 2.272 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.02 |
| Regular Market Change Percent | 0.884955 |
| Regular Market Day High | 2.355 |
| Regular Market Day Low | 2.24 |
| Regular Market Day Range | 2.24 - 2.355 |
| Regular Market Open | 2.26 |
| Regular Market Previous Close | 2.26 |
| Regular Market Price | 2.28 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 198,306 |
| Return On Assets | -0.34238997 |
| Return On Equity | -0.86816 |
| Revenue Growth | 0.373 |
| Revenue Per Share | 0.752 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 41,267,511 |
| Shares Percent Shares Out | 0.0082 |
| Shares Short | 377,502 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 216,880 |
| Short Name | Rapid Micro Biosystems, Inc. |
| Short Percent Of Float | 0.014199999 |
| Short Ratio | 1.45 |
| Source Interval | 15 |
| State | MA |
| Symbol | RPID |
| Target High Price | 8.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 8.0 |
| Target Median Price | 8.0 |
| Total Cash | 38,729,000 |
| Total Cash Per Share | 0.852 |
| Total Debt | 23,874,000 |
| Total Revenue | 33,587,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.35555 |
| Two Hundred Day Average Change | -1.0755501 |
| Two Hundred Day Average Change Percent | -0.3205287 |
| Type Disp | Equity |
| Volume | 198,306 |
| Website | https://www.rapidmicrobio.com |
| Zip | 2,421 |